taxifolin has been researched along with Amyloid Angiopathy, Cerebral in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, R; Yang, X; Zhang, F | 1 |
| Katasonov, AB | 1 |
| Ihara, M; Inoue, T; Saito, S; Satoh-Asahara, N; Tanaka, M | 2 |
| Fukushima, M; Harada-Shiba, M; Hattori, Y; Ihara, M; Ito, H; Kalaria, RN; Maki, T; Mizuno, K; Saito, S; Takahashi, R; Yamamoto, Y | 1 |
| Ihara, M; Inoue, T; Kusakabe, T; Saito, S; Satoh-Asahara, N; Shimatsu, A; Tanaka, M; Yamakage, H | 1 |
3 review(s) available for taxifolin and Amyloid Angiopathy, Cerebral
| Article | Year |
|---|---|
New Perspectives of Taxifolin in Neurodegenerative Diseases.
Topics: Alzheimer Disease; Cerebral Amyloid Angiopathy; Humans; Neurodegenerative Diseases; Quercetin | 2023 |
Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Biomarkers; Brain; Cerebral Amyloid Angiopathy; Cilostazol; Disease Models, Animal; Humans; Membrane Glycoproteins; Mice; Neuroprotective Agents; Oxidative Stress; Protein Aggregation, Pathological; Quercetin; Receptors, Immunologic | 2020 |
Novel Therapeutic Potentials of Taxifolin for Amyloid-β-associated Neurodegenerative Diseases and Other Diseases: Recent Advances and Future Perspectives.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cerebral Amyloid Angiopathy; Humans; Neuroprotective Agents; Quercetin | 2019 |
3 other study(ies) available for taxifolin and Amyloid Angiopathy, Cerebral
| Article | Year |
|---|---|
[Dihydroquercetin as a systemic neuroprotector for the prevention and treatment of β-amyloid-associated brain diseases].
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Cerebral Amyloid Angiopathy; Humans | 2023 |
Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy.
Topics: Amyloid beta-Peptides; Animals; Cerebral Amyloid Angiopathy; Cerebrovascular Circulation; Disease Models, Animal; Humans; Male; Memory Disorders; Mice, Inbred C57BL; Mice, Transgenic; Neuroprotective Agents; Nootropic Agents; Protein Aggregation, Pathological; Quercetin; Random Allocation; Receptor for Advanced Glycation End Products; Spatial Memory | 2017 |
Pleiotropic neuroprotective effects of taxifolin in cerebral amyloid angiopathy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Cerebral Amyloid Angiopathy; Drug Evaluation, Preclinical; Endoplasmic Reticulum Stress; Lymphatic Vessels; Male; Mice; Microglia; Quercetin; Random Allocation | 2019 |